A Randomized, Double-Blind, Placebo-Controlled Proof of Concept Study to Evaluate LB1148 for Return of Gastrointestinal Function, Post-Operative Ileus and Intra-Abdominal Adhesions in Subjects Undergoing Elective Bowel Resection

Trial Profile

A Randomized, Double-Blind, Placebo-Controlled Proof of Concept Study to Evaluate LB1148 for Return of Gastrointestinal Function, Post-Operative Ileus and Intra-Abdominal Adhesions in Subjects Undergoing Elective Bowel Resection

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 17 Nov 2017

At a glance

  • Drugs Tranexamic acid (Primary)
  • Indications Adhesions; Gastrointestinal disorders; Postoperative ileus
  • Focus Proof of concept; Therapeutic Use
  • Acronyms PROFILE
  • Sponsors Leading BioSciences
  • Most Recent Events

    • 10 Nov 2017 Planned End Date changed from 1 Sep 2018 to 1 Nov 2020.
    • 10 Nov 2017 Planned primary completion date changed from 1 Nov 2017 to 1 Jan 2020.
    • 10 Nov 2017 Planned initiation date changed from 1 Sep 2016 to 1 Nov 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top